The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma

被引：0
|
作者：
Shuang Lu
Chenglong Wang
Yun Liu
Funing Chu
Zhengyan Jia
Hongkai Zhang
Zhaoqi Wang
Yanan Lu
Shuting Wang
Guang Yang
Jinrong Qu
机构：
[1] the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital,Department of Radiology
[2] East China Normal University,Shanghai Key Laboratory of Magnetic Resonance
来源：
European Radiology | 2024年 / 34卷
关键词：
Magnetic resonance imaging; Esophageal squamous cell carcinoma; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 494
页数：9
相关论文
共 50 条
  • [1] The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma
    Lu, Shuang
    Wang, Chenglong
    Liu, Yun
    Chu, Funing
    Jia, Zhengyan
    Zhang, Hongkai
    Wang, Zhaoqi
    Lu, Yanan
    Wang, Shuting
    Yang, Guang
    Qu, Jinrong
    EUROPEAN RADIOLOGY, 2024, 34 (01) : 485 - 494
  • [2] CT radiomics to predict pathologic complete response after neoadjuvant immunotherapy plus chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
    Shi, Liqiang
    Li, Chengqiang
    Bai, Yaya
    Cao, Yuqin
    Zhao, Shengguang
    Chen, Xiaoyan
    Cheng, Zenghui
    Zhang, Yajie
    Li, Hecheng
    EUROPEAN RADIOLOGY, 2025, 35 (03) : 1594 - 1604
  • [3] Can MRI Predict Pathologic Complete Response After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer?
    Lee, C.
    Le-Tran, V.
    Olimpiadi, Y.
    Zaremba, N.
    Nelson, M.
    Lang, J. E.
    Sener, S. F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S90 - S90
  • [4] A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Yang, Yalan
    Xin, Dao
    Wang, Huike
    Guan, Lulu
    Meng, Xiangrui
    Lu, Taiying
    Bai, Xiwen
    Wang, Feng
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1443 - 1455
  • [5] DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
    Qu, Jinrong
    Ma, Ling
    Lu, Yanan
    Wang, Zhaoqi
    Guo, Jia
    Zhang, Hongkai
    Yan, Xu
    Liu, Hui
    Kamel, Ihab R.
    Qin, Jianjun
    Li, Hailiang
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [6] DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
    Jinrong Qu
    Ling Ma
    Yanan Lu
    Zhaoqi Wang
    Jia Guo
    Hongkai Zhang
    Xu Yan
    Hui Liu
    Ihab R. Kamel
    Jianjun Qin
    Hailiang Li
    Discover Oncology, 13
  • [7] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Survival benefits of adjuvant chemotherapy for patients with residual pathologic disease after neoadjuvant chemotherapy and surgery for locally advanced esophageal squamous cell carcinoma
    Lu, Hao
    Liu, Jun-Feng
    Rong, Yu
    Liu, Xin-Bo
    Wang, Yan
    JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (06) : 867 - 869
  • [9] Baseline CT radiomics features to predict pathological complete response of advanced esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy using paclitaxel and cisplatin
    Ou, Jing
    Zhou, Hai-ying
    Qin, Hui-lin
    Wang, Yue-su
    Gou, Yue-qin
    Luo, Hui
    Zhang, Xiao-ming
    Chen, Tian-wu
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 181
  • [10] The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma
    Song, Tao
    Yao, Qi
    Qu, Jinrong
    Zhang, Hongkai
    Zhao, Yan
    Qin, Jianjun
    Feng, Wen
    Zhang, Shouning
    Han, Xianhua
    Wang, Shaoyu
    Yan, Xu
    Li, Hailiang
    EUROPEAN RADIOLOGY, 2021, 31 (03) : 1391 - 1400
12345